U.S. Markets open in 34 hrs, 54 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,496.57 | 49.91 | 0.44% |
| NASDAQ | 2,282.78 | -29.52 | -1.28% |
| S&P 500 | 1,260.68 | 0.36 | 0.03% |
| Day Low 09:32 AM EDT | 9.90 | |
|---|---|---|
| Day High 03:51 PM EDT | 10.35 |
|
| Range | 0.45 | |
| Volume | 768,123 | |
| 30-Day Avg. Vol. | 981,000 |
|
| Difference | -21.70% | |
| Market Cap. | 1.66 B | |
| Change | 64.4 M | |
| Shares Out. | 161.02 M | |
| Percent Traded | 0.48% | |
| Revenue | — | |
| Earnings | — | |
| EPS (TTM) | 0.99 |
| 52-Wk Low 7/1/08 | 9.38 | |
|---|---|---|
| 52-Wk High 7/18/07 | 25.63 |
|
| Range | 16.25 | |
| Prev. Close 7/17/08 | 9.91 | |
| Today's Open | 9.98 | |
| Change | 0.71% | |
| Dividend (TTM) | — | |
| Div. Yield (TTM) | — |
|
| Beta | 1.1251 | |
| P/E Ratio (TTM) | 10.41 | |
| P/E Ratio (Fwd.) | — |
Specialty pharmaceutical firm Biovail specializes in making improved versions of existing drugs using its oral drug delivery technologies, such as extended release and oral disintegration formulations. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | — — | — — |
—
—
|
| Last Quarter | — — | — — |
—
—
|
| Quarterly - | Annual - | |
|---|---|---|
| Total Revenue | — | — |
| Gross Profit | — | — |
| Operating Income | — | — |
| Net Income | — | — |
Real-Time Quote
